Nigeria has formally joined the African Medicines Agency (AMA) Treaty, becoming the 34th African Union member state to ratify the agreement. This development is a significant boost to efforts to strengthen medicines regulation and combat fake and substandard drugs across the continent. The announcement was made by the African Union Commissioner for Health, Humanitarian Affairs and Social Development, Amb. A. Twum-Amoah, at the inaugural AMA Week in Kigali, Rwanda.
The AMA is a continental body established to strengthen the regulation of medicines and medical products, ensuring they meet required standards of safety, quality and effectiveness. Nigeria's ratification signals its commitment to a coordinated African regulatory system aimed at protecting public health, promoting local drug manufacturing and improving access to safe, effective and affordable medicines. This move is expected to have a positive impact on the country's pharmaceutical sector.
Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, who attended the conference, described Nigeria's ratification as a major step towards strengthening Africa's health security and pharmaceutical sovereignty. Adeyeye emphasized that Nigeria's position as Africa's most populous country and one of its largest pharmaceutical markets would strengthen the continent's collective efforts to harmonize medicines regulation.
Adeyeye also stressed that ratification must translate into concrete action through sustained institutional cooperation and effective implementation of the treaty. She highlighted the importance of cooperation between NAFDAC, AMA and other national and regional regulatory agencies, particularly in regulatory capacity building, information sharing and scientific collaboration. This cooperation is crucial for the success of the AMA.
The success of the AMA will ultimately depend on its ability to ensure that Africans have access to safe, effective, quality-assured and affordable medicines, backed by stronger national regulatory agencies. Adeyeye described Nigeria's ratification as more than a diplomatic or legal achievement, saying it represented a significant investment in Africa's health security, pharmaceutical sovereignty and sustainable development. This investment is expected to have long-term benefits for the continent.
Nigeria's ratification of the AMA treaty is a significant milestone in the country's efforts to strengthen its pharmaceutical sector. The country has a large and growing pharmaceutical market, and its participation in the AMA is expected to improve the regulation of medicines and medical products. This, in turn, will have a positive impact on public health and the economy.
The African Medicines Agency is expected to play a critical role in promoting public health and protecting the safety and well-being of Africans. With Nigeria's ratification, the AMA now has 34 member states, and the agency is one step closer to achieving its goal of a coordinated African regulatory system. The AMA's success will depend on the continued cooperation and commitment of its member states.
Key points
- Nigeria has become the 34th African Union member state to ratify the African Medicines Agency treaty.
- The ratification is expected to strengthen medicines regulation and combat fake and substandard drugs across the continent.
- Nigeria's participation in the AMA is expected to improve the regulation of medicines and medical products, and have a positive impact on public health and the economy.
